AAAAAA

   
Results: 1-11 |
Results: 11
High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH
Authors: Bruder, CEG Hirvela, C Tapia-Paez, I Fransson, I Segraves, R Hamilton, G Zhang, XX Evans, DG Wallace, AJ Baser, ME Zucman-Rossi, J Hergersberg, M Boltshauser, E Papi, L Rouleau, GA Poptodorov, G Jordanova, A Rask-Andersen, H Kluwe, L Mautner, V Sainio, M Hung, G Mathiesen, T Moller, C Pulst, SM Harder, H Heiberg, A Honda, M Miimura, M Sahlen, S Blennow, E Albertson, DG Pinkel, D Dumanski, JP
Citation: Ceg. Bruder et al., High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH, HUM MOL GEN, 10(3), 2001, pp. 271-282
Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis
Authors: Laurent-Puig, P Legoix, P Bluteau, O Belghiti, J Franco, D Binot, F Monges, G Thomas, G Bioulac-Sage, P Zucman-Rossi, J
Citation: P. Laurent-puig et al., Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis, GASTROENTY, 120(7), 2001, pp. 1763-1773
Molecular characterization of germline NF2 gene rearrangements
Authors: Legoix, P Sarkissian, HD Cazes, L Giraud, S Sor, F Rouleau, GA Lenoir, G Thomas, G Zucman-Rossi, J
Citation: P. Legoix et al., Molecular characterization of germline NF2 gene rearrangements, GENOMICS, 65(1), 2000, pp. 62-66
NF2 gene deletion in a family with a mild phenotype
Authors: Lopez-Correa, C Zucman-Rossi, J Brems, H Thomas, G Legius, E
Citation: C. Lopez-correa et al., NF2 gene deletion in a family with a mild phenotype, J MED GENET, 37(1), 2000, pp. 75-77
Characterisation of 16 polymorphic markers in the NF2 gene: Application tohemizygosity detection
Authors: Legoix, P Legrand, MF Ollagnon, E Lenoir, G Thomas, G Zucman-Rossi, J
Citation: P. Legoix et al., Characterisation of 16 polymorphic markers in the NF2 gene: Application tohemizygosity detection, HUM MUTAT, 13(4), 1999, pp. 290-293
Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity
Authors: Legoix, P Bluteau, O Bayer, J Perret, C Balabaud, C Belghiti, J Franco, D Thomas, G Laurent-Puig, P Zucman-Rossi, J
Citation: P. Legoix et al., Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity, ONCOGENE, 18(27), 1999, pp. 4044-4046
Cryptic exons as a source of increased diversity of Ewing tumor-associatedEWS-FLI1 chimeric products
Authors: Kovar, H Jugovic, D Melot, T Zoubek, A Lenoir, G Fink, FM Philip, I Turc-Carel, C Thomas, G Zucman-Rossi, J
Citation: H. Kovar et al., Cryptic exons as a source of increased diversity of Ewing tumor-associatedEWS-FLI1 chimeric products, GENOMICS, 60(3), 1999, pp. 371-374
PCR-based genotyping can generate artifacts in LOH analyses
Authors: Bluteau, O Legoix, P Laurent-Puig, P Zucman-Rossi, J
Citation: O. Bluteau et al., PCR-based genotyping can generate artifacts in LOH analyses, BIOTECHNIQU, 27(6), 1999, pp. 1100-1102
Semi-automated quantitative method for detecting the loss of heterozygosity at chromosome 4 in hepatocellular carcinoma
Authors: Bluteau, O Legoix, P Bayer, J Bioulac-Sage, P Flejou, JF Capron, F Monges, G Brechot, C Thomas, G Laurent-Puig, P Zucman-Rossi, J
Citation: O. Bluteau et al., Semi-automated quantitative method for detecting the loss of heterozygosity at chromosome 4 in hepatocellular carcinoma, GASTRO CL B, 23(11), 1999, pp. 1225-1232
Neurofibromatosis type-2 (Tumor suppressor gene)
Authors: Soussi, T Aurias, A Giovannini, M Zucman-Rossi, J
Citation: T. Soussi et al., Neurofibromatosis type-2 (Tumor suppressor gene), B CANCER, 86(12), 1999, pp. 963-964
NF2 gene in neurofibromatosis type 2 patients
Authors: Zucman-Rossi, J Legoix, P Der Sarkissian, H Cheret, G Sor, F Bernardi, A Cazes, L Giraud, S Ollagnon, E Lenoir, G Thomas, G
Citation: J. Zucman-rossi et al., NF2 gene in neurofibromatosis type 2 patients, HUM MOL GEN, 7(13), 1998, pp. 2095-2101
Risultati: 1-11 |